← Back to Clinical Trials
Recruiting NCT05661318

AHC Ballana Heart Study

Trial Parameters

Condition Genetic Predisposition to Disease
Sponsor Magdi Yacoub Heart Foundation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2018-01-01
Completion 2050-12-31
Interventions
Risk assessment

Brief Summary

This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.

Eligibility Criteria

Inclusion criteria: * Residents of Ballana from the 1,200 randomly selected households * Participants must have a valid National ID card * Written informed consent Exclusion criteria: • Residents who are younger than 18 years

Related Trials